Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine.
Saved in:
| Title: | Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine. |
|---|---|
| Authors: | Martins RM; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil., Périssé ARS; National School of Public Health, Fiocruz, Rio de Janeiro, RJ, Brazil., Camacho LAB; National School of Public Health, Fiocruz, Rio de Janeiro, RJ, Brazil., Leal ML; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil., Maia MLS; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil., Homma A; Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil., Jessouroun E; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil. Electronic address: ellen@bio.fiocruz.br. |
| Source: | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases [Braz J Infect Dis] 2021 Nov-Dec; Vol. 25 (6), pp. 101652. Date of Electronic Publication: 2021 Nov 16. |
| Publication Type: | Clinical Trial, Phase I; Journal Article |
| Journal Info: | Publisher: Elsevier Editora Country of Publication: Brazil NLM ID: 9812937 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1678-4391 (Electronic) Linking ISSN: 14138670 NLM ISO Abbreviation: Braz J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1678-4391 |
|---|---|
| DOI: | 10.1016/j.bjid.2021.101652 |
